Article

Structure-based inhibitors reveal roles for the clathrin terminal domain and its W-box…

medRxiv · 2020 · Chen, Z.; Mino, R.; Mettlen, M.; Michaely, P.; Bhave, M.; Reed, D. K.; Schmid, S. L.

Key facts

Title Structure-based inhibitors reveal roles for the clathrin terminal domain and its W-box binding site in CME
First author Chen, Z.; Mino, R.; Mettlen, M.; Michaely, P.; Bhave, M.; Reed, D. K.; Schmid, S. L.
Journal medRxiv
Published Jan 25, 2020
DOI 10.1101/2020.01.24.919092
Devices mentioned BK110039, K914390
Product codes mentioned DDG, PCA, KIT, MVU, NDS, NJT

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature